PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Genscript Biotech Corp (1548.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINKYG3825B1059
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapHK$25.87B
PE Ratio115.65
Revenue (TTM)HK$839.53M
Gross Profit (TTM)HK$303.48M
EBITDA (TTM)-HK$358.52M
Year RangeHK$10.34 - HK$24.95
Target PriceHK$29.31

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Genscript Biotech Corp

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Genscript Biotech Corp, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%December2024FebruaryMarchAprilMay
849.90%
156.28%
1548.HK (Genscript Biotech Corp)
Benchmark (^GSPC)

S&P 500

Returns By Period

Genscript Biotech Corp had a return of -37.46% year-to-date (YTD) and -35.71% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-37.46%10.00%
1 month-2.66%2.41%
6 months-47.59%16.70%
1 year-35.71%26.85%
5 years (annualized)-8.46%12.81%
10 years (annualized)N/A10.84%

Monthly Returns

The table below presents the monthly returns of 1548.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-34.74%22.07%-8.34%-19.72%-37.46%
20236.44%-18.90%-21.68%22.62%-15.92%1.62%13.41%-7.92%12.35%9.93%-4.41%-8.48%-20.08%
2022-28.55%25.15%-18.64%-9.36%1.98%22.63%-0.18%-10.39%-32.57%15.62%-0.40%25.76%-27.97%
2021-12.23%35.15%2.24%31.58%69.17%11.33%0.59%8.36%-18.81%15.17%18.67%-15.85%205.85%
20201.92%-10.09%-22.56%10.19%22.83%-5.67%5.40%-10.83%-15.35%-15.30%3.72%1.26%-35.89%
201914.01%21.93%0.95%34.95%-15.30%15.82%-1.12%-9.38%-14.56%25.43%0.32%-6.35%67.61%
201842.39%-17.40%6.81%6.18%9.94%-25.94%-11.52%-11.98%-21.78%-9.53%13.71%-22.35%-47.15%
2017-5.41%16.00%3.45%-17.62%-4.62%28.33%-1.42%73.80%3.18%27.75%4.20%101.21%441.89%
20164.54%-2.90%2.24%-8.75%-3.21%-1.65%5.05%74.40%0.46%45.20%26.10%-7.73%180.31%
20150.00%0.00%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 1548.HK is 12, indicating that it is in the bottom 12% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of 1548.HK is 1212
1548.HK (Genscript Biotech Corp)
The Sharpe Ratio Rank of 1548.HK is 1111Sharpe Ratio Rank
The Sortino Ratio Rank of 1548.HK is 1313Sortino Ratio Rank
The Omega Ratio Rank of 1548.HK is 1515Omega Ratio Rank
The Calmar Ratio Rank of 1548.HK is 1515Calmar Ratio Rank
The Martin Ratio Rank of 1548.HK is 33Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Genscript Biotech Corp (1548.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


1548.HK
Sharpe ratio
The chart of Sharpe ratio for 1548.HK, currently valued at -0.72, compared to the broader market-2.00-1.000.001.002.003.004.00-0.72
Sortino ratio
The chart of Sortino ratio for 1548.HK, currently valued at -0.92, compared to the broader market-4.00-2.000.002.004.006.00-0.92
Omega ratio
The chart of Omega ratio for 1548.HK, currently valued at 0.90, compared to the broader market0.501.001.502.000.90
Calmar ratio
The chart of Calmar ratio for 1548.HK, currently valued at -0.55, compared to the broader market0.002.004.006.00-0.55
Martin ratio
The chart of Martin ratio for 1548.HK, currently valued at -1.54, compared to the broader market-10.000.0010.0020.0030.00-1.54
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.35, compared to the broader market-2.00-1.000.001.002.003.004.002.35
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.33, compared to the broader market-4.00-2.000.002.004.006.003.33
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.41, compared to the broader market0.501.001.502.001.41
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.90, compared to the broader market0.002.004.006.001.90
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.02, compared to the broader market-10.000.0010.0020.0030.009.02

Sharpe Ratio

The current Genscript Biotech Corp Sharpe ratio is -0.72. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Genscript Biotech Corp with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.72
2.32
1548.HK (Genscript Biotech Corp)
Benchmark (^GSPC)

Dividends

Dividend History

Genscript Biotech Corp granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.00 per share.


PeriodTTM2023202220212020201920182017
DividendHK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.06%

Monthly Dividends

The table displays the monthly dividend distributions for Genscript Biotech Corp. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2017HK$0.01HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-70.39%
-0.33%
1548.HK (Genscript Biotech Corp)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Genscript Biotech Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Genscript Biotech Corp was 75.11%, occurring on Apr 19, 2024. The portfolio has not yet recovered.

The current Genscript Biotech Corp drawdown is 70.39%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-75.11%Jul 20, 2021678Apr 19, 2024
-70.7%Jan 30, 2018224Dec 27, 2018597Jun 3, 2021821
-41.28%Mar 21, 201744May 26, 201766Aug 30, 2017110
-37.35%Jan 20, 201686May 27, 201662Aug 26, 2016148
-25.98%Sep 15, 201710Sep 28, 20178Oct 12, 201718

Volatility

Volatility Chart

The current Genscript Biotech Corp volatility is 18.72%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%December2024FebruaryMarchAprilMay
18.72%
3.36%
1548.HK (Genscript Biotech Corp)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Genscript Biotech Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items